Gabapentin for behavioral agitation in Alzheimer's disease.
Regan
W M
WM
Gordon
S M
SM
D000085:Acetates / Q000627:therapeutic use*; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D000588:Amines; D000927:Anticonvulsants / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D000077206:Gabapentin; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D011595:Psychomotor Agitation / Q000188:drug therapy*; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D006220:Haloperidol